Exchange: NASDAQ·Updated 07:30 PM EDT
SCYX logo

SCYX Scynexis Inc

$5.39
$0.13
(2.35%)
Today
Closed $5.39
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$53.63M
Vol56,836.00

About SCYX

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
45

Neutral Sentiment

How do you feel about SCYX?

Advertisement|Remove ads.